BackHansa Biopharma AB (publ) Overview

Hansa Biopharma AB (publ) Current Cash

Latest current cash for HNSBF: $1.3B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.34B
↑ 434.16% YoYΔ $1.09B vs prior year quarter

Peer trimmed avg / median

Loading

Hansa Biopharma AB (publ) Current Cash History

Loading

Hansa Biopharma AB (publ) vs. peers: Current Cash Comparison

Loading

Hansa Biopharma AB (publ) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Hansa Biopharma AB (publ) (HNSBF) FAQ

As of the most recent data (September 2026), HNSBF shows a current cash of $1.3B. That compares with $250M in the prior-year period — up 434.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HNSBF's current cash is now $1.3B (was $250M) — a 434.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hansa Biopharma AB (publ) is outperforming or lagging.

Tracking HNSBF's current cash over time shows whether Hansa Biopharma AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3B That compares with $250M in the prior-year period — up 434.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Hansa Biopharma AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.3B) with ownership activity and broader fundamentals.

Hansa Biopharma AB (publ)'s current cash is $1.3B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.